EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Monitoring Apoptosis and Myeloid Differentiation of Acridine Orange‐Mediated Sonodynamic Therapy‐Induced Human Promyelocytic Leukemia HL60 Cells

Metin Caliskan iD, Rahsan Ilikci-Sagkan iD, Gulsen Bayrak iD, Sercin Ozlem-Caliskan iD

Journal of Ultrasound in Medicine · 2025

DOI: 10.1002/jum.16575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ultrasound in Medicine, 2025. Verfasst von Metin Caliskan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Usak University, Usak, Turkey. Hauptthemen laut MEDLINE: Apoptosis, Ultrasonic Therapy, Cell Differentiation, Acridine Orange. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

In the treatment of acute myeloid leukemia (AML), conventional therapies can lead to severe side effects and drug resistance. There is a need for alternative treatments that do not cause treatment resistance and have minimal or no side effects. Sonodynamic therapy (SDT), due to its noninvasive, multiple repeatability, localized treatment feature and do not cause treatment resistance, emerges as an alternative treatment option. However, it has not received sufficient attention in the treatment of AML especially acute promyelocytic leukemia (APL). The aim of the study was to investigate the potential differentiation and antileukemic effects of acridine orange (AO)‐mediated SDT on HL60 cells.

Methods

Cell viability was determined by the 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) method in the control, ultrasound, AO concentrations, and ultrasound‐exposed AO concentrations groups. Transmission electron microscopy (TEM) was used to determine morphology, and flow cytometry was used to determine apoptosis, DNA cycle, cell volume, mitochondria membrane potential (Δψm), reactive oxygen species (ROS) production, and differentiation markers (CD11b and CD15) expressions. Additionally, toluidine blue staining for semithin sections was used to determine differentiation.

Results

The cytotoxicity of AO‐mediated SDT on HL60 cells was significantly higher than other groups, and TEM images showed that it caused various morphological changes typical for apoptosis. Flow cytometry results showed the presence of early apoptosis, subG1 arrest, loss of Δψm, increase of intracellular ROS production, decreased cell volume, and increased expression of CD11b (1.3‐fold) antigen and CD15 (1.2‐fold) antigen.

Conclusion

Data showed that AO‐mediated SDT significantly induced apoptosis in HL60 cells. Increased expression of CD11b and CD15 antigens and morphological findings demonstrated that AO‐mediated SDT contributes to granulocytic differentiation in HL60 cells. AO‐mediated SDT has potential as an alternative treatment of APL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisUltrasonic TherapyCell DifferentiationAcridine OrangeLeukemia, Promyelocytic, AcuteHumansHL-60 CellsCell Survival

Stichwörter der Autor:innen

HL60 cellsacridine orangedifferentiation therapysonodynamic therapy

Substanzen

Acridine Orange

Autor:innen und Institutionen

  • Department of Medical Biology, Faculty of Medicine, Usak University, Usak, Turkey.
  • Department of Histology and Embryology, Faculty of Medicine, Usak University, Usak, Turkey.
  • Department of Biophysics, Faculty of Medicine, Usak University, Usak, Turkey.

ORCID-Profile: Metin Caliskan, Rahsan Ilikci-Sagkan, Gulsen Bayrak, Sercin Ozlem-Caliskan

Zitieren

APA

Caliskan, M., Ilikci-Sagkan, R., Bayrak, G., & Ozlem-Caliskan, S. (2025). Monitoring Apoptosis and Myeloid Differentiation of Acridine Orange‐Mediated Sonodynamic Therapy‐Induced Human Promyelocytic Leukemia HL60 Cells. Journal of Ultrasound in Medicine. https://doi.org/10.1002/jum.16575

Vancouver

Caliskan M, Ilikci-Sagkan R, Bayrak G, Ozlem-Caliskan S. Monitoring Apoptosis and Myeloid Differentiation of Acridine Orange‐Mediated Sonodynamic Therapy‐Induced Human Promyelocytic Leukemia HL60 Cells. Journal of Ultrasound in Medicine. 2025. doi:10.1002/jum.16575

BibTeX
@article{Caliskan2025,
  author = {Caliskan, Metin and Ilikci-Sagkan, Rahsan and Bayrak, Gulsen and Ozlem-Caliskan, Sercin},
  title = {Monitoring Apoptosis and Myeloid Differentiation of Acridine Orange‐Mediated Sonodynamic Therapy‐Induced Human Promyelocytic Leukemia HL60 Cells},
  journal = {Journal of Ultrasound in Medicine},
  year = {2025},
  doi = {10.1002/jum.16575}
}
Kostenlos starten →